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Abstract
Zinc is an essential trace element required for bone formation, however not much has been clarified yet for its role in osteoblast. We hypothesized 
that zinc would increase osteogenetic function in osteoblasts. To test this, we investigated whether zinc treatment enhances bone formation by stimulating 
osteoblast proliferation, bone marker protein alkaline phosphatase activity and collagen synthesis in osteoblastic MC3T3-E1 cells. MC3T3-E1 cells
were cultured and treated with various concentrations of zinc (0, 1, 3, 15, 25 uM) along with a normal osteogenic medium (OSM) as control for 
1, 5, 10 days. As measured by MTT assay for mitochondrial metabolic activity, cell proliferation was stimulated even at low zinc treatment (1-3
μM) compared to OSM, and it was stimulated in a zinc concentration-dependent manner during 5 and 10 days, with the most pronounced effect
at 15 and 25 uM Zn. Cellular (synthesized) alkaline phosphatase (ALP) activity was increased in a zinc concentration-dependent manner, so did
medium (secreted) ALP activity. Cellular collagen concentration was increased by zinc as time went by, therefore with the maximum zinc stimulatory
effect in 10 days, and medium collagen concentration showed the same pattern even on 1 and 5 day. This zinc stimulatory effect of collagen synthesis
was observed in cell matrix collagen staining. The study results imply that zinc can increase osteogenic effect by stimulating cell  proliferation, 
ALP activity and collagen synthesis in osteoblastic cells.
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Introduction2)
Bone mass is maintained through the repeated cycle of 
destruction and rebuilding
  to maintain the balance between bone 
formation and bone resorption which are controlled by 
osteoblasts and osteoclasts [1]. Bone formation is a complex 
biological process and involves several tightly regulated gene 
expression patterns of bone-related proteins [2]. The basic 
processes that involve bone formation are considerably similar 
to the development of other organs except for the unique 
mineralization phase involving the attachment of calcium and 
phosphate, along with collagenous and other noncollagenous 
proteins, to form the structural integrity and framework of mature 
skeletal bone. Normal maturation of bone cell relies upon 
complex cell-cell and cell matrix interactions in a highly 
temporally and spatially coordinated manner [3] that involves 
successive developmental stages including proliferation, bone 
matrix maturation, mineralization and bone-remodeling [4]. The 
regulation of hormones and other molecules secreted by either 
osteoblast or osteoclast tightly controls the dynamic and complex 
process of bone remodeling thus bone formation [5]. 
Zinc is an essential trace element to the structure and function 
of metabolism [6]. Zinc deficiency decreases bone weight and 
delays growth in bone metabolism. Zinc deficiency results in a 
retardation of bone growth, development, and maintenance of 
bone health [7,8]. Zinc has a stimulatory effect on bone formation 
and mineralization in vivo and vitro [9,10]. Zinc is also implicated 
in the stimulation of collagen production in rat femora and 
calvaria [11]. It has been shown that zinc acts to increase bone 
formation and mineralization, decrease bone resorption and 
stimulate alkaline phosphatase (ALP) activity, in both calvaral 
organ cultures and osteoblast cell cultures [9,11-13]. The cellular 
mechanism of zinc action in osteoblastic cells has not fully 
clarified. Zinc demonstrated stimulating cell proliferation and 
differentiation, as well as protein synthesis in osteoblatic cells 
[14,15]. Once bone matrix synthesis begins in osteoblast culture 
models, such as osteoblastic MC3T3-E1 cells, the cells 
differentiate in accordance with the gene activation and protein 
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synthesis of osteoblast markers. Alkaline phosphatase (ALP) is 
one of the most representative bone marker proteins for osteoblast 
differentiation [16,17]. 
In this study, we evaluated whether zinc could increase 
osteoblast proliferation and differentiation which can be measured 
by collagen synthesis and alkaline phosphatase (ALP) activity 
as an indicator for osteoblast differentiation, using mouse 
osteoblastic MC3T3-E1 cells. In addition, matrix Ca deposits by 
zinc treatment were also examined for matrix mineralization. The 
study results showed the anabolic role of zinc on bone formation 
in osteoblast model.
Materials and Methods
Reagents
Mouse calvariae origin osteoblastic MC3T3-E1 subclone 4 
(ATCC, CRL-2593, subclone 4, highly differentiating osteoblast) 
was obtained from ATCC Cell Bank (Manassas, VA, USA). Cell 
culture reagents (α-MEM, penicillin & streptomycin and fetal 
bovine serum) were obtained from Gibco Laboratories (Grand 
Island, NY, USA). Chemicals were obtained from Sigma (St 
Louis, MO), unless otherwise noted. All consumables reagents 
and plastic wares used were trace element free analysis grade.
Cell culture and zinc-treatment
MC3T3-E1 cells were seeded at a density of 1x10
5 cells/mL 
and maintained in regular growth medium (α-MEM with 10% 
FBS, 1mM sodium pyruvate and 1% penicillin and streptomycin) 
in a humidified atmosphere of 5% CO2 at 37℃. At 80% 
confluence, cells were treated with various concentrations of zinc 
(0, 1, 3, 15, 25 uM) in the form of ZnCl2 with the addition 
of 5 µM TPEN (N,N,N’,N’-tetrakis-(2-pyridylmethyl)-Ethylene-
diamine, intracellular cell-permeable zinc-chelator) for the 
depletion of zinc in the media serum. TPEN is the intercellular 
zinc chelating agent and each TPEN molecule binds a single 
zinc atom through 4 pyridine rings and so the molar ratio is 
one [18]. Zinc addition at these levels also ensured maintenance 
of cell viability and the physiological relevance of the zinc 
treatment conditions. Normal physiological zinc level in 
mammalian animals and humans is about 15 μM [6,19]. ZnCl2 
or ZnSO4 is normally used for the cellular zinc treatment, and 
in the present study, ZnCl2 was used for external zinc treatment 
for the cell culture. Normal osteogenic differentiation medium 
(OSM, growth media plus 10 mM β-glycerophosphate and 
50µg/mL L-ascorbic acid without TPEN addition) was used 
as control group. Cells were cultured with zinc-treated media 
for 1, 5 and 10 days and the media were changed every 2-3 
days. 
Cell proliferation by MTT assay
Cell proliferation by treatment of 0-25 µM zinc under 5 µM 
TPEN during 1, 5 and 10 days was determined by MTT assay 
on the metabolic reduction of 3-[4,5-dimethylthiazol-2-y]-2,5- 
diphenyltetrazolium bromide (MTT). Briefly, cells were plated 
at seeding MC3T3-E1 cells (1x10
4 cells/well in 96-well plate) 
and maintained in growth media for 24 hours at 5% CO2 at 37℃. 
At 80% confluence, the cells were treated with zinc for 1, 5 
and 10 days. Then, 10 µl of MTT solution was added in each 
well and incubated at 37℃ for 3 hours to allow for the formation 
of formazan crystals. After formation of formazan crystals, MTT 
medium was then aspirated and replaced with solubilization 
solution (DMSO) for dissolving the formazan crystals. The plates 
were read on Micro Elisa reader (Asys Hitee, Expert 96, Asys 
Co, Austria) at 570 nm. 
Cellular and media alkaline phosphatase activity assay and 
protein assay
ALP activity of MC3T3-E1 cells and media were measured. 
Cells were washed with PBS and lysed in 1 mL of 0.02% 
Triton-X in 0.9% NaCl before subjecting to sonication for 30s 
twice on ice. The sonicated lysates were centrifuged for 15 min 
at 12,000 rpm. The supernatant was kept at -20℃ until analysis. 
The activity of ALP in cell lysates and media was measured 
using ρ-nitrophenylphosphate (PNPP) as the substrate and the 
optical density for the enzyme products was measured at 405 
nm. Cellular protein concentration was measured by the Bradford 
method, with bovine serum albumin as the standard. The activity 
of cellular ALP expressed as nmol PNPP/mg of protein/min. The 
activity of medium ALP was expressed as nmol PNPP/mL/min. 
Cellular and media collagen concentration 
Collagen concentration in the cells and the media were 
measured. The cell lysates and medium samples were centrifuged 
and the supernatants were stored at -70℃ until use. Collagen 
standards were prepared using collagen type I, and calibration 
was obtained for their absorbance values in a range of 0 to 400 
μg/ml. After the samples being thawed, the collected supernatants 
were centrifuged again. Fifty microliters of sample and collagen 
standard were added in each well of a 96-well plate. The plates 
containing the supernatant, sample, and standard were incubated 
at 37℃ consecutively for 16 h in a humidified atmosphere, and 
24 h in a dry oven. After incubation, all the wells were washed 
3 times with 200 μl of distilled water. Clean wells were filled 
with 100 μl of 0.1% (w/v) Sirius red F3BA in saturated picric 
acid. Staining lasted 1 h at 37℃ in a dry incubator. The plates 
were finally washed 5 times for 10 seconds with 200 μl of 10 
mM HCl solution. The samples underwent a further step in 0.1 
N NaOH for 5 minutes at room temperature to dissolve the 
adsorbed collagen. The solution was mixed several times and 358 Zn stimulation for ALP and collagen in osteoblasts
Fig. 1. Proliferation of osteoblastic MC3T3-E1 cells by zinc treatment for 1, 5 
and 10 days. Cell proliferation of MC3T3-E1 cells by zinc treatment were measured 
by MTT assay. The values are presented as %OSM as normal osteogenic medium. 
Different superscripts mean significant difference by zinc treatments at P < 0.05 by 
Tukey,  ANOVA.  Data  presented  as  mean ± SEM  (n = 10). 
Fig. 2. ALP activity in osteoblastic MC3T3-E1 cells by zinc. Alkaline phosphatase
(ALP) activity in MC3T3-E1 cells (synthesized ALP, A) and the media (secreted ALP, 
B)  treated  with  zinc.  Different  superscripts  mean  significant  different  among  zinc 
treatments at P<0.05 by Tukey, one-way ANOVA. Data presented as mean ± SEM 
(n = 3).  ALP  one  unit  of  ρ- n i t r o p h e n o l  a s  p r o d u c t s  b e i n g  c o n v e r t e d  f r o m  
p-nitrophenyl phosphate as substrate for 30 minute reaction time. (cellular ALP 1 
unit = a nmole ρ -nitrophenol/mg of protein/30 min, medium ALP 1 unit = 1 nmole 
p-nitrophenol/ml/30  min)
transferred into a clean plate. Finally, the absorbance at 540 nm 
was measured using an ELISA reader (TECAN, Austria). 
Collagen concentration was normalized to the protein concentration 
which was measured by Bradford method. 
Collagen staining
To evaluate extracellular matrix collagen synthesis, cellular 
matrix was stained using Van Gieson’s stain method. At days 
of 1, 5 and 10, cells were washed with PBS twice, and then 
fixed with 2% formaldehyde for 15 min at 4 C. The cells were 
stained with Van Gieson’s stain for 5 min at room temperature 
and rinsed with deionized water twice. The images of stained 
cells were captured using a phase contrast microscope with digital 
camera (IM50, Leica, Germany).
Alizarin red S staining
To measure extracellular matrix Ca deposits for bone nodule 
formation, cellular matrix was stained using Alizarin red S dye 
which combines with Ca on matrix. At the differentiation days 
of 1, 5 and 10, cells were washed with PBS twice, and then 
fixed with 4.0% formaldehyde. The cells were stained with 40 
mM of Alizarin red S solution at pH 4.4 for 40 min at room 
temperature and rinsed with deionized water twice. The images 
of stained cells were captured using a phase contrast microscope 
with digital camera (IM50, Leica, Germany).
Statistical analysis 
Data were analyzed using software SPSS-17.0. Values for cell 
proliferation by MTT assay for absorbance are presented as the 
mean ± SEM. The data analysis was performed using one way 
ANOVA and Tukey’s HSD test as post hoc test was applied 
if significance was determined. Differences were considered as 
being significant at P < 0.05.
Results
Effect of zinc on osteoblast proliferation
MC3T3-E1 cell proliferation was increased as time went by 
in a zinc concentration-dependent manner (Fig. 1). Cell 
proliferation was stimulated even at low zinc treatment (1-3 M) 
at day 1, compared to OSM. As time went by, this zinc-stimulated 
cell proliferation was more prominent at high range of zinc 
concentration at 15 and 25 uM Zn on day 5 and 10, while low 
zinc level showed the adverse effect of cell proliferation during 
this culture period. 
Results show that the stimulatory effect for cell proliferation 
was shown by zinc treatment. MC3T3-E1 cells cultured in 0 μM 
Zn had decrease in cell proliferation as compared to OSM during Hyun-Ju Seo et al. 359
Fig. 3. Collagen synthesis in osteoblastic MC3T3-E1 cells by zinc. Cellular and 
medium collagen concentration was measured as described in Methods. Different 
superscripts  mean  significant  difference  among  zinc  treatments  at  P < 0.05  by 
T u k e y ,  o n e  w a y  A N O V A .  D a t a  p r e s e n t e d  a s  m e a n±S E M  ( n=3 ) . 
Fig. 4. Collagen staining by zinc treatment in MC3T3-E1 cells for 1 , 5 and 
10 days. Cell matrix collagen was stained using Van Gieson's staining method as 
described on Method. Magnification rate, ×100 (1days) or ×40 (5 and 10 days). 
Representative  image  of  8  replicates  in  24-well  plate. 
Fig. 5. Alizarin Red S staining for Ca deposits (bone nodule) by zinc treatment 
in MC3T3-E1 cells for 1, 5 and 10 days. Cells were cultured at 24-well plates 
for  1,  5,  and  10  days  with  the  0-25  mM  zinc  treatment.  Extracellular  matrix  Ca 
deposits for matrix mineralization was measured using Alizarin red S dye which binds 
with Ca. Magnification rate, ×100. Representative image of 8 replicates in 24-well 
plate. 
1 day. And MC3T3-E1 cells cultured in 0 and 1 μM Zn also 
had decrease in cell proliferation as compared to OSM during 
osteogenic period (5 and 10 days). This suggests that 0 and 1 
μM Zn medium with the 5 μM TPEN treatment causes an adverse 
effect in the cell proliferation which may not be appropriate for 
prolonged cell culture. During 5 and 10 days of zinc treatment, 
the significant increase of cell proliferation was shown with a 
zinc-concentration dependent manner. 
Cellular (synthesized) and medium (secreted) ALP activity by zinc
To evaluate the effect of zinc on the differentiation of 
osteoblastic MC3T3-E1 cells, we examined the activity of ALP, 
a marker of osteoblastic differentiation, on day 1, 5, and 10 of 
osteoblast proliferation and differentiation period both in cells 
(Fig. 2A) and media (Fig. 2B). Cellular (synthesized) and 
medium (secreted) ALP activity was stimulated by zinc in a 
concentration-dependent manner at day 1, 5, and 10. Cellular 
ALP activity was increased in a zinc concentration-dependent 
manner, especially day 1, at the range of 15 and 25 μM Zn 
treatments, compared to normal osteogenic differentiation media 
(OSM). Medium ALP activity was also shown as the same pattern 
with cellular ALP activity. Medium ALP activity by zinc 
treatment was shown more prominent zinc concentration- 
dependent manner up to 10 days, which can be interpreted that 
it might be due that ALP is the secretory enzyme out of the 
cell to the extracellular matrix. Medium ALP was increased by 
zinc treatment during 1, 5 and 10 days particularly at the range 
of 15 and 25 μM Zn, compared to OSM. These data showed 
that zinc treatment stimulated cellular and medium ALP activity. 360 Zn stimulation for ALP and collagen in osteoblasts
Cellular (synthesized) and medium (secreted) collagen concentra-
tion by zinc
Collagen synthesis is also a major marker of osteoblastic 
differentiation therefore we assessed the effect of zinc on 
collagen concentration in osteoblastic MC3T3-E1 cells both in 
cells (Fig. 3A) and media (Fig. 3B) during 10 days. Cellular 
collagen concentration was increased at higher zinc concentra-
tions as time went by, especially at day 10 at the zinc concentra-
tion of 3-25 μM Zn treatment. Since collagen is cell membrane- 
attached and secretory protein, medium collagen concentration 
was also measured. Medium collagen concentration was increased 
with zinc concentration-dependent manner at day 1 and the 
pattern in which zinc treatment increased collagen concentration 
up to 10 days. 
Collagen in cell matrix was also stained (Fig. 4). Cellular and 
matrix collagen was increased as zinc concentration increased, 
as which was shown on collagen concentration in cells and media. 
Collagen synthesis was also increased with time-dependent 
manner in cell matrix layers (Fig. 4).
Alizarin red S for mineralization by zinc
In addition to osteoblast proliferation and differentiation, such 
as collagen synthesis and ALP activity, extracellular matrix 
mineralization is also one of the major part of bone formation, 
and we assessed whether zinc treatment to MC3T3-E1 cells 
stimulated matrix mineralization which increases the anabolic 
activity in bone metabolism. Extracellular matrix Ca deposits for 
mineralised nodule formation were stained with Alizarin red S 
dye which combines with Ca ions and the calcified nodules 
appeared bright red colour by Alizarin red S staining (Fig. 5). 
Alizarin red S staining showed the sign that zinc treatment has 
the tendency to increase extracellular matrix Ca accumulation. 
However, in the present study, due to the shortage of zinc 
treatment duration for inducing calcification (since normally Ca 
deposits are very active around 10-15 days), Ca deposits in matrix 
was not prominent yet, up to 10 days. It was observed that zinc 
increased matrix Ca deposits with zinc concentration- and 
time-dependent manner during 5-10 days on MC3T3-E1 cells. 
Discussion
Zinc is a trace element, essential for the function of normal 
mammalian cell processes such as DNA [20,21] and protein 
synthesis [12,22,23]. In the present study, we investigated the 
possible effect of zinc on osteoblast proliferation and differentiation 
which was measured for the indicators of osteoblast differentia-
tion, collagen concentration and alkaline phosphatase (ALP) 
activity, in MC3T3-E1 cells. Pre-osteoblasts, like the MC3T3-E1 
cells, differentiate into osteoblasts, which is accompanied by a 
coordinated expression of a series of extracellular matrix (ECM) 
proteins, collagenous and noncollagenous proteins such as 
collagen type I and ALP, respectively [3]. At the proliferation 
phase of pre-osteoblastic to osteoblastic cells, the cells undergo 
DNA synthesis and cell division resulting in a rapid increase 
in cell number, which finally increases the expression of the 
osteogenic phenotype as well. In the present study, zinc increases 
cellular proliferation in osteoblatic MC3T3- E1 cells as time went 
by during 1-10 days, which is considered as stimulating osteoblast 
differentiation by bone marker protein synthesis by osteoblasts.
The presence of mature osteoblasts during the proliferation 
phase is indicated by the production of ALP, processing of 
procollagen to collagen, and the deposition of extracellular matrix 
containing additional proteins which would later be mineralized 
[24,25]. Thus, ALP activity and collagen synthesis are the most 
widely recognised biochemical markers for osteoblastic activity. 
These two proteins are typical proteins for osteoblast-phenotype 
and osteoblast differentiation [24,26]. Therefore, in general, ALP 
synthesis and ALP activity, and collagen synthesis are increased 
as osteoblasts are differentiating especially from the early stage 
of osteogenesis. In addition, ALP also contains zinc as part of 
its homodimeric metalloenzymes which contain zinc as the 
component [19,27]. 
ALP protein is known to be secreted from the cells after it 
is being synthesized and its expression heralds the stage at which 
differentiation is believed to be nonreversible in most systems 
studied. This agrees with the result of this study, since an 
increased ALP activity pattern by zinc treatment was observed 
from the proliferation (1 and 5 days) to matrix maturation and 
early mineralization phase (10 days). This pattern was more 
prominent in medium ALP activity (Fig. 2B), which is matched 
with the normal pattern of secretory protein like ALP. In this 
study, zinc increased ALP activity at cellular level at day 1 and 
10 (Fig. 2A), which is considered as that zinc stimulates ALP 
synthesis, therefore can stimulate osteoblast differentiation. Also 
this increased ALP protein in cells is secreted outside the cells, 
which is confirmed by the same pattern of zinc-stimulated ALP 
activity in media (Fig. 2B). Therefore, these increased ALP 
protein synthesis and enzyme activity in cells and medium can 
be interpreted as the indication of osteoblast differentiation and 
bone matrix maturation. 
Collagen synthesis is also well known as a sign of osteoblast 
differentiation. It has been reported by Bremner and Beattie [19] 
and Wallwork and Sandstead [28] that zinc deficiency affects 
both the biosynthesis and degradation of all type of collagen. 
In the present study, cellular collagen concentration was 
increased by zinc treatment as time went by. Cellular collagen 
level was not immediately increased by zinc treatment on day 
1. But it was increased as time went by, therefore collagen level 
in cells were the highest at the highest zinc treatment level (25 
mM) at day 10, with the higher collagen concentration (Fig. 3A). 
This pattern of the increased collagen concentration at 10 days 
would be considered that collagen proteins as secretory protein 
were accumulated in cells and cell layers as time went by. Also, 
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medium collagen synthesis was also measured [19,28]. While 
cellular collagen level was accumulated as zinc- and time- 
dependent manner, medium collagen concentration showed the 
more prominent zinc stimulator effect for collagen synthesis at 
day 1 with the zinc-dependent manner. In addition, collagen 
synthesis measured by staining collagen protein in cell layers 
showed the same pattern of cellular collagen level by zinc 
treatment (Fig. 4). These increased collagen synthesis and 
accumulation by zinc treatment in osteoblasts can be considered 
as the sign of stimulating the bone matrix and osteoblast maturation. 
Mineralization of extracellular matrix as Ca deposits for 
mineralised nodule formation was also assessed by staining by 
Alizarin red S dye which combines with Ca ions (Fig. 5). Even 
there is a sign of zinc stimulatory effect for ECM Ca deposits, 
however, Ca deposits were not prominently observed probably 
due to the immature ECM calcification yet at day 10 in this study.
Taken all together, it is suggested that zinc can increase 
osteogenic effect by increasing cell proliferation and stimulating 
ALP and collagen synthesis during the proliferation and 
differentiation phase in osteoblastic MC3T3-E1 cells. Therefore, 
zinc can increase bone formation through increasing osteoblast 
cell growth and cellular ALP and collagen synthesis in 
MC3T3-E1 cells. The future work needs to be focused on how 
and where-by these ALP and collagen synthesis modulated by 
zinc to clarify the osteogenic role of zinc.
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